126 related articles for article (PubMed ID: 23669293)
1. CYP19A1 gene polymorphisms and risk of lung cancer.
Zhang J; Yin Y; Niu XM; Liu Y; Garfield D; Chen SF; Wang R; Wang L; Chen HQ
J Int Med Res; 2013 Jun; 41(3):735-42. PubMed ID: 23669293
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
[TBL] [Abstract][Full Text] [Related]
3. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
4. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
6. Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population.
Miao R; Gu H; Liu H; Hu Z; Jin G; Wang H; Wang Y; Sun W; Ma H; Chen D; Tian T; Jin L; Wei Q; Lu D; Huang W; Shen H
Lung Cancer; 2008 Dec; 62(3):281-6. PubMed ID: 18495292
[TBL] [Abstract][Full Text] [Related]
7. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
[TBL] [Abstract][Full Text] [Related]
9. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk.
Jang JS; Kim KM; Choi JE; Cha SI; Kim CH; Lee WK; Kam S; Jung TH; Park JY
Mol Carcinog; 2008 May; 47(5):383-90. PubMed ID: 18058802
[TBL] [Abstract][Full Text] [Related]
10. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking.
Liang G; Miao X; Zhou Y; Tan W; Lin D
Carcinogenesis; 2004 May; 25(5):773-8. PubMed ID: 14688021
[TBL] [Abstract][Full Text] [Related]
11. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
13. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
[TBL] [Abstract][Full Text] [Related]
14. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
15. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients.
Jou YS; Lo YL; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen YM; Huang MS; Chen HL; Chen CJ; Yang PC; Hsiung CA
Lung Cancer; 2009 Jun; 64(3):251-6. PubMed ID: 19026460
[TBL] [Abstract][Full Text] [Related]
16. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
Okasaka T; Matsuo K; Suzuki T; Ito H; Hosono S; Kawase T; Watanabe M; Yatabe Y; Hida T; Mitsudomi T; Tanaka H; Yokoi K; Tajima K
J Hum Genet; 2009 Dec; 54(12):739-45. PubMed ID: 19881468
[TBL] [Abstract][Full Text] [Related]
17. DNMT3B polymorphisms and risk of primary lung cancer.
Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer.
Putra AC; Tanimoto K; Arifin M; Hiyama K
Respirology; 2011 Jul; 16(5):796-802. PubMed ID: 21435097
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
20. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
